Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in activities of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), bulk drugs, branded and generic formulations. It is focused on development, manufacturing and supply of amino acids, nutritional supplements and API for pharmaceutical, nutraceuticals and food industries. It operates through three segments: APIs, Finished Dosage Formulations (FDFs), and Intermediates. Its APIs include Ascorbic Acid IP, Sodium Ascorbate, Ferrous Ascorbate, and others. Its Intermediary products include Calcium Phosphoryl Choline Chloride (CPCC) and Chlorhexidine (CH Base). It offers a range of FDFs forms, including tablets, caplets, capsules, and oral powders, all available in bulk quantities. The FDFs products include Cholecalciferol Sachet, Ticagrelor Tablet, Pancreatin Capsules, levofloxacin Tablets IP, Bisacodyl Tablet IP, and others.
Bajaj Healthcare Financial Highlights
- Revenue: Bajaj Healthcare reported revenue of ₹618.16 crore in FY26 vs ₹562.00 crore in FY25. It showed an increase of 9.99% on a yearly basis.
- Operating Profit: Bajaj Healthcare reported an operating profit of ₹28.92 crore in FY26 vs ₹46.01 crore in FY25. It showed a decrease of 37.14% on a year-on-year basis.
- Net Profit: Bajaj Healthcare reported a net profit of ₹15.77 crore in FY26 vs ₹39.50 crore in FY25. It showed a decrease of 60.08% on a yearly basis.
Bajaj Healthcare Quarterly Result Highlights
- Bajaj Healthcare reported revenue of ₹166.44 crore in Jun 2026, compared with ₹156.02 crore in Mar 2026, representing an increase of 6.68% on a quarter-on-quarter (QoQ) basis.
- Bajaj Healthcare reported an operating profit of ₹16.46 crore in Jun 2026, compared with ₹20.81 crore in Mar 2026, representing an increase of 179.10% on a quarter-on-quarter (QoQ) basis.
- Bajaj Healthcare reported a profit of ₹13.70 crore in Jun 2026, compared with ₹22.85 crore in Mar 2026, reflecting an increase of 159.96% on a QoQ basis.
- The earnings per share (EPS) of Bajaj Healthcare stood at ₹13.29 during Jun 2026.